Advocacy in Action #NBCCsummit

Several staff members from the Delaware Breast Cancer Coalition recently attended the National Breast Cancer Coalition (NBCC) Advocacy Summit in Washington, DC. It was a wonderful summit where staff members were updated on the latest efforts to achieve Deadline 2020: to know how to end breast cancer by January 1, 2020 and advocate to leverage government to help us achieve our goals.  NBCC President, Fran Visco, shared so many stories with us of the triumph and tribulations the organization has faced over the last 25 years. We were inspired to live up to our goals so we can stop losing the ones we love to this horrible disease. #NBCCSummit

IMG_5315

There were updates from panels of experts in science, research, women’s health, and more on the Artemis Project – the search for a preventative breast cancer vaccine, prevention, metastasis, the political climate of breast cancer, and advocacy training.  All of this learning prepared us to march to Capitol Hill to meet with our legislators and effect change in our communities. #NBCConthehill

Our voices were heard as we met with staff members from all our legislative offices. In Congressman Carney’s office we met with staff aid, Gita Miller, who assured us of Congressman Carney’s continued support for the fight against breast cancer. He has already signed on as a Co-Sponsor for H.R. 1197 the bill which will help us Accelerate the End of Breast Cancer.  We urged the Congressman to help put pressure on the leadership in the U.S. House of Representatives to bring the bill to a suspension vote. We hope we can count on Congressman Carney to reach out to Representative Hoyer and Representative McCarthy to bring the bill to a suspension vote, where it will undoubtedly pass! Our Congressman will continue to make cancer a priority in his office.

 

IMG_5354

 

Quick detour as we stopped at the Supreme Court for a photo-op. #wheninDC

Next, we proceeded to the Senate side where we met with Senator Coons’ aid Kelsey Mellette to discuss the Senators unrelenting support for the efforts of the National Breast Cancer Coalition. Not only is Senator Coons a cosponsor for S. 746 Accelerating the End of Breast Cancer Act, but he has signed onto the FY17 letter to the Defense Appropriations Subcommittee in support of funding for the DOD peer-reviewed Breast Cancer Research Program (BCRP). This program has been so successful in producing innovative and unique, effective research which is both accountable to the public and transparent, and has produced extraordinary results. It has led to revolutionary work including the breast cancer drug, Herceptin. We are grateful to have Senator Coons support in Washington!

IMG_5357

Lastly, we met with Senator Carper’s aid Lynn Sha to discuss Carper’s support. Senator Carper has signed on as a cosponsor for S. 746 Accelerating the End of Breast Cancer Act and we hope we can count on his support of the DOD BCRP in the future.

IMG_5369

The conference was intense but we found some time for fun. Meeting the faculty for a quick chat about his ongoing research and a photo.

IMG_5322

And when it came time for the Breast Cancer Caucus “Convention”, we showed our Delaware pride BIG time! Check out our team pictured with Abe from the Washington Nationals and our University of Delaware Pride!

Overall, we learned a lot and had a great time. We will continue to fight to achieve the deadline and stop ending deaths due to breast cancer. If you would like to learn more about the National Breast Cancer Coalition and becoming an advocate, please contact Beth at bkrallis@debreastcancer.org.

Delaware Federal Lawmakers Support Legislation to End Breast Cancer

Lawmakers Co-Sponsor Legislation to Support the National Breast Cancer Coalition’s Deadline 2020

DOVER, DE (October 28, 2015)— The Delaware Breast Cancer Coalition (DBCC) is pleased to announce that Congressman John Carney, Senator Tom Carper, and Senator Chris Coons have declared their support as Co-Sponsors for the Accelerating the End of Breast Cancer Act (S. 746/ H.R. 1197). The Accelerating the End of Breast Cancer Act is a bipartisan bill that will focus on identifying strategies for primary prevention, stopping women and men from getting breast cancer, and understanding and preventing metastasis—the spread of cancer—which is responsible for 90% of breast cancer deaths.

 

The Deadline Breast Cancer Coalition supports the National Breast Cancer Coalition’s advocacy efforts to know how to end Breast Cancer by January 1, 2020. Through research, access and influence, the National Breast Cancer Coalition’s efforts are both ambitious and achievable.

 

“More than 750 Delawareans will be diagnosed with breast cancer this year, and thousands more across the country will lose their battle with this deadly disease,” Senator Coons said. “Innovative research has transformed breast cancer diagnosis and treatment, but breast cancer rates have continued to rise, and women today face a greater risk of contracting the disease than they did four decades ago. It’s time to scale up our efforts to combat this disease, so we can move closer to our goal of eliminating breast cancer by 2020. It is clear that ending breast cancer is beyond a political issue. It is up to the leaders of this nation to work together to support the Accelerating the End of Breast Cancer Act so we can end morbidity and mortality due to this disease.”

 

According to the Delaware Breast Cancer Coalition’s Executive Director Vicky Cooke, the Accelerating the End of Breast Cancer Act is one major step needed to achieve the Deadline. “I am a breast cancer survivor and I am a proud mother and grandmother. I support Deadline 2020 so my children and my grandchildren won’t have to face breast cancer and we can stop losing our loved ones to this horrific disease. I don’t want to cure it, because a cure implies you have to get it. I want to end it. And in Delaware, we are proud and grateful to have one hundred percent support from our Congressional leaders.”

 

To learn more about Deadline 2020 or the National Breast Cancer Coalition, visit http://www.breastcancerdeadline2020.org.

IMG_3228 IMG_3236 IMG_3241 015_DBCC_20150612 016_DBCC_20150612 027_DBCC_20150612

About DBCC:

The Delaware Breast Cancer Coalition is a 501(c)(3) organization offering statewide programs and services of education, outreach, and early detection and treatment of breast cancer. Its mission is to create a community where every person diagnosed with breast cancer is a survivor, and fear and doubt are replaced with knowledge and hope.

Headquartered in Wilmington with offices in Sussex and Kent Counties, DBCC’s programs reach diverse communities to deliver messages that address their unique concerns about breast cancer and early detection. Recognizing the barriers of language, culture, and economics, DBCC trains community advocates to educate and encourage women to take responsibility for breast health. DBCC helps women with low incomes and those with little or no insurance to receive free or reduced-cost care.

DBCC also supports the National Breast Cancer Coalition and their research efforts by helping to facilitate participation in local clinical trials. All funds raised for DBCC support programs in Delaware and the neighboring areas in Pennsylvania, Maryland, and New Jersey.

For more information about the Delaware Breast Cancer Coalition, call 866-312-DBCC (3222) or visit the website at www.debreastcancer.org.

###

Two DBCC Staff Members Complete NBCC’s Project LEAD Training in California

Two DBCC Staff Members, Kelly Kershaw and Caitlin Dalik, both of the Wilmington office, graduated from the National Breast Cancer Coalition (NBCC) Project LEAD Institute.  Kelly and Caitlin participated in the course on July 17-22, 2011 in La Jolla, California.  The course enrolled 50 breast cancer advocates from all over the country.  The Project LEAD Institute is an intensive 6-day course which trains breast cancer advocates in the science of breast cancer so that they can better understand and analyze breast cancer research and policy.  The course included lessons on the language and concepts of cancer biology, basic epidemiology, research methodology, and more.  Several other DBCC Staff members have also completed the course.

Photo caption: Kershaw (left) and Dalik of the Delaware Breast Cancer Coalition on a Project LEAD Institute field trip at The Scripps Research Institute in La Jolla, California.  Scripps is a medical research facility that focuses on research in the basic biomedical sciences.